Diagnostic yield, safety and therapeutic consequences of myocardial biopsy in clinically suspected fulminant myocarditis unweanable from mechanical circulatory support.

Background: Fulminant myocarditis is a rare and severe disease whose definite and etiological diagnoses rely on pathological examination. Albeit, myocardial biopsy can be associated with significant morbidity and mortality, its therapeutic consequences are unclear. We conducted a study to determine...

Descripción completa

Detalles Bibliográficos
Publicado en:Annals of Intensive Care Vol. 13; no. 1; pp. 1 - 13
Autores principales: Marquet, Yann, Hékimian, Guillaume, Lebreton, Guillaume, Kerneis, Mathieu, Rouvier, Philippe, Bay, Pierre, Mathian, Alexis, Bréchot, Nicolas, Chommeloux, Juliette, Petit, Matthieu, Gautier, Melchior, Lefevre, Lucie, Saura, Ouriel, Levy, David, Quentric, Paul, Moyon, Quentin, Ortuno, Sofia, Schmidt, Matthieu, Leprince, Pascal, Luyt, Charles-Edouard
Formato: Journal Article
Publicado: Elsevier B.V. 8/31/2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=171309952&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 171309952
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        21105820
        ESHV
      jtl: Annals of Intensive Care
      issn: 21105820
      maglogo: N
    pubinfo:
      dt: 8/31/2023
      vid: 13
      iid: 1
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        171309952
        10.1186/s13613-023-01169-y
        171309952
      ppf: 1
      ppct: 12
      formats:
      tig:
        atl: Diagnostic yield, safety and therapeutic consequences of myocardial biopsy in clinically suspected fulminant myocarditis unweanable from mechanical circulatory support.
      aug:
        au:
          Marquet, Yann
          Hékimian, Guillaume
          Lebreton, Guillaume
          Kerneis, Mathieu
          Rouvier, Philippe
          Bay, Pierre
          Mathian, Alexis
          Bréchot, Nicolas
          Chommeloux, Juliette
          Petit, Matthieu
          Gautier, Melchior
          Lefevre, Lucie
          Saura, Ouriel
          Levy, David
          Quentric, Paul
          Moyon, Quentin
          Ortuno, Sofia
          Schmidt, Matthieu
          Leprince, Pascal
          Luyt, Charles-Edouard
        affil: Service de Médecine Intensive-Réanimation, Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital La Pitié–Salpêtrière, 47–83, Boulevard de l'Hôpital, 75651, Paris Cedex, France
      sug:
      ab: Background: Fulminant myocarditis is a rare and severe disease whose definite and etiological diagnoses rely on pathological examination. Albeit, myocardial biopsy can be associated with significant morbidity and mortality, its therapeutic consequences are unclear. We conducted a study to determine the diagnostic yield, the safety and the therapeutic consequences of myocardial biopsy in patients with fulminant clinically suspected myocarditis unweanable from mechanical circulatory support (MCS). Methods: Monocenter, retrospective, observational cohort study in a 26-bed French tertiary ICU between January 2002 and February 2019. Inclusion of all fulminant clinically suspected myocarditis patients undergoing in-ICU myocardial biopsy while being on MCS. The primary endpoint was the proportion of patients classified as definite myocarditis using Bonaca criteria before and after including myocardial biopsy results. Results: Forty-seven patients (median age 41 [30–47], female 53%) were included: 55% died before hospital discharge, 34% could be bridged-to-recovery and 15% bridged-to-transplant. Myocardial biopsy was endomyocardial or surgical in 36% and 64% cases respectively. Tamponade requiring emergency pericardiocentesis occurred in 29% patients after endomyocardial biopsy. After adding the biopsy results in the Bonaca classification algorithm the percentage of definite myocarditis raised from 13 to 55% (p < 0.0001). The rate of biopsy-related treatments modifications was 13%, leading to patients' recovery in only 4% patients. Conclusions: In clinically suspected myocarditis unweanable from MCS, myocardial biopsy increased the rate of definite myocarditis but was associated with a low rate of treatment modification and a significant proportion of adverse events. We believe the benefit/risk ratio of myocardial biopsy should be more carefully weighted in these frail and selected patients than suggested by actual guidelines. Further prospective studies are now needed to determine its value in patients under MCS.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N